Dolby Laboratories (NYSE:DLB) SVP John Couling Sells 7,667 Shares of Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $61.05, for a total transaction of $468,070.35. Following the completion of the sale, the senior vice president owned 118,727 shares in the company, valued at $7,248,283.35. This represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Dolby Laboratories Price Performance

DLB opened at $61.95 on Friday. The company has a fifty day moving average price of $56.41 and a 200-day moving average price of $58.30. The firm has a market capitalization of $5.80 billion, a P/E ratio of 26.36 and a beta of 0.80. Dolby Laboratories has a one year low of $48.26 and a one year high of $73.78.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.02. The firm had revenue of $305.00 million for the quarter, compared to analysts’ expectations of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business’s quarterly revenue was down 3.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, analysts expect that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 61.28%.

Dolby Laboratories announced that its board has authorized a stock repurchase plan on Thursday, July 30th that allows the company to repurchase $350.00 million in outstanding shares. This repurchase authorization allows the electronics maker to reacquire up to 7% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds have recently added to or reduced their stakes in DLB. Fifth Third Bancorp increased its position in shares of Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after purchasing an additional 192 shares during the last quarter. Aquatic Capital Management LLC bought a new stake in Dolby Laboratories in the 3rd quarter worth approximately $56,000. iSAM Funds UK Ltd bought a new stake in Dolby Laboratories in the 3rd quarter worth approximately $68,000. Quarry LP boosted its stake in Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock worth $76,000 after buying an additional 1,115 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in Dolby Laboratories by 48.4% in the fourth quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock worth $79,000 after buying an additional 402 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on DLB. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Weiss Ratings lowered shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, August 13th. Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a report on Friday, August 28th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $83.00.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.